Meihua Intl Med Technologies
13F holders, Q2 2024 (June 30)6holders −1
1new positions
2sold out
1famous investor
$0.85avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Meihua Intl Med Technologies in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Anson Funds Management LP ($553K), Renaissance Technologies ($21K) and UBS Group AG ($19K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Meihua Intl Med Technologies
- CUSIP
- G5966G108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19K |
| Exits | 2 | $29K |
All 13F filers, Q1 2024 → Q2 2024: 308,651 shares bought and 39,329 shares sold, net +269,322 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Anson Funds Management LP | 0.08% | Add +74.8% | 648,603 | $553K |
| Renaissance Technologies | 0.00% | Reduce -5.1% | 24,300 | $21K |
| UBS Group AG | 0.00% | New | 22,734 | $19K |
| Marex Group Ltd | 0.00% | Add +70.4% | 20,000 | $17K |
| Geode Capital Management, LLC | 0.00% | No change | 16,753 | $14K |
| Morgan Stanley | 0.00% | No change | 2,786 | $2K |
"% of holder's portfolio" is MEIHUA INTL MED TECHNOLOGIES's weight in each manager's 13F, not the share of Meihua Intl Med Technologies the manager owns.